Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Debt / NOTE 4.750% 5/0
-
Market price (% of par)
-
88.53%
-
Total 13F principal
-
$124,177,000
-
Principal change
-
+$5,246,000
-
Total reported market value
-
$110,191,485
-
Number of holders
-
19
-
Value change
-
+$4,929,001
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0 as of Q3 2022
As of 30 Sep 2022 PARATEK PHARMACEUTICALS INC - NOTE 4.750% 5/0 had 19 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $124,177,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, DeepCurrents Investment Group LLC, MACQUARIE GROUP LTD, Athyrium Capital Management, LP, SILVERBACK ASSET MANAGEMENT LLC, Verition Fund Management LLC, AGF Investments LLC, AGF INVESTMENTS INC., and PALISADE CAPITAL MANAGEMENT LLC/NJ.
This table shows 19 bond principal holders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.